Article Text

Download PDFPDF
CASE REPORT
Inflammatory flaccid myelitis in a patient with both anti-CRMP-5 IgG and CNS HIV escape
  1. Rajan P Arora1,
  2. Andrew K Treister1,
  3. Maile Y Karris2 and
  4. Ronald J Ellis1
  1. 1 Department of Neurosciences, University of California San Diego, San Diego, California, USA
  2. 2 Department of Medicine, University of California San Diego, San Diego, California, USA
  1. Correspondence to Dr Andrew K Treister, andrewtreistermd{at}gmail.com

Abstract

Anticollapsin-responsive mediator protein 5 (CRMP-5) IgG is an antibody generally associated with small-cell lung cancer, which is known to cause paraneoplastic neurological syndromes, including encephalitis, myelitis and neuropathy. HIV escape is a phenomenon in which a patient with low or undetectable levels of HIV RNA in plasma is found to have elevated levels in cerebrospinal fluid (CSF). We present a case of a 58-year-old HIV-positive woman with undetectable plasma viral load who developed a subacute flaccid paraparesis. Over the course of 4 months, she had a broad inflammatory and infectious workup that was unrevealing until repeat imaging showed an inflammatory myelitis. Workup was notable for elevated HIV RNA copies in CSF, as well as anti-CRMP-5 autoantibodies in serum. Despite changing her antiretroviral therapy and multiple modalities of immunomodulation, the patient failed to respond adequately to treatment. This case illustrates a complex clinical picture with a unique presentation of anti-CRMP-5 myelitis.

  • HIV/AIDS
  • spinal cord
  • immunology

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors RPA and AKT drafted the original manuscript and performed the literature review. MYK and RJE provided substantial revisions.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests MYK reports grants from GS-US-311-1717 (Gilead Sciences) outside the submitted work. The other authors have nothing to disclose.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Patient consent for publication Obtained.